Medtronic and cosmo pharmaceuticals forge ahead in ai-driven care

Agreement expands partnership between medtronic and cosmo pharmaceuticals, set to transform endoscopy with cutting-edge ai technology dublin , dec. 11, 2023 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with cosmo intelligent medical devices, a subsidiary of cosmo pharmaceuticals. this ai-driven partnership will further capitalize on the achievements already realized with the gi genius™ intelligent endoscopy module, offering continued innovation and scalable healthcare advancements for patients and caregivers globally.
MDT Ratings Summary
MDT Quant Ranking